Results 211 to 220 of about 34,369,254 (402)
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
Case Reports: Add Value Beyond the Impact Factor
Marshall Journal of Medicine, 2019 Darshana T. Shah
doaj +1 more source
Egyptian Journal of Chest Diseases and Tuberculosis, 2016 Mohamed Awad Tageldin, Iman Galal
openaire +2 more sources
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
PRIMARY MALIGNANT GROWTH OF THE LIVER IN INFANTS: WITH REPORT OF A RECENT CASE. [PDF]
, 1922 C.B. Dansie
openalex +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source
REPORT OF A CASE OF RETROGRADE URETERAL CALCULUS [PDF]
, 1919 Ester M. E. Sundelöf
openalex +1 more source